Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H28O2 |
Molecular Weight | 288.4244 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CCC4=CC(=O)CC[C@]34C
InChI
InChIKey=MUMGGOZAMZWBJJ-DYKIIFRCSA-N
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1
Molecular Formula | C19H28O2 |
Molecular Weight | 288.4244 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:17:03 UTC 2023
by
admin
on
Fri Dec 15 15:17:03 UTC 2023
|
Record UNII |
3XMK78S47O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
52590
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
49043-3
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
NDF-RT |
N0000175824
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2990-0
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
76352-4
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2986-8
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
WHO-VATC |
QG03EA02
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
34380-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
83116-4
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
59229-5
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
25987-9
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LIVENSA (SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL )
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
26827-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LIVERTOX |
944
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
26826-8
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
CFR |
21 CFR 862.1680
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2987-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
NCI_THESAURUS |
C2298
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
NDF-RT |
N0000008241
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2993-4
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
49041-7
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2994-2
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
13486-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
104197
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
35225-2
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
49042-5
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
59240-2
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
523916
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
59233-7
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
855921
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
WHO-VATC |
QG03BA03
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2988-4
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
16286-7
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Testosterone
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
15095-3
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
31030-0
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
WHO-ATC |
G03EA02
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
WHO-ATC |
G03BA03
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
73570-4
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2984-3
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
15432-8
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2991-8
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
14914-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
41018-3
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
35224-5
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2992-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
17685-9
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
59219-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRINSA (WITHDRAWN: SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL)
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
48357-8
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
94595
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
10631-0
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
51005-7
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
18.2
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
27306-0
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
CFR |
21 CFR 862.1430
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
70239-9
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
CFR |
21 CFR 310.528
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
70240-7
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
15094-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2985-0
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
2989-2
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
6891-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
83115-6
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
14913-8
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
17687-5
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
DEA NO. |
4000
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
LOINC |
25986-1
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
||
|
NDF-RT |
N0000000146
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3XMK78S47O
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
9700
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
17347
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
200-370-5
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
TESTOSTERONE
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
58-22-0
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
D013739
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
3398
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
2858
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
DB00624
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
1900
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
C862
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
3XMK78S47O
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
1646009
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
6013
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
Testosterone (medication)
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
100000089191
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL386630
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
Testosterone
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
DTXSID8022371
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
10379
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB10937MIG
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
2607
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | |||
|
m10594
Created by
admin on Fri Dec 15 15:17:04 UTC 2023 , Edited by admin on Fri Dec 15 15:17:04 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
ENZYME->SUBSTRATE |
Vmax
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
BINDING
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
In reproductive tissues, dihydrotestosterone is further metabolized to 3-alpha and 3-beta androstanediol
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE TOXIC -> PARENT |
Metabolite shown to induce pyrogenic and inflammatory reactions in man.
|
||
|
PARENT -> METABOLITE |
URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
DHT binds with greater affinity to SHBG than does testosterone
MAJOR
|
||
|
METABOLITE -> PARENT |
In reproductive tissues, dihydrotestosterone is further metabolized to 3-alpha and 3-beta androstanediol
|
||
|
METABOLITE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE ACTIVE -> PARENT | |||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
By glucuronosyl transferase (UGT)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|